indomethacin has been researched along with Acute Necrotizing Pancreatitis in 3 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beburishvili, AG | 1 |
| Ziubina, EN | 1 |
| Turovets, MI | 1 |
| Mandrikov, VV | 1 |
| Li, GD | 1 |
| Jia, XY | 1 |
| Dong, HY | 1 |
| Pang, QP | 1 |
| Zhai, HL | 1 |
| Zhang, XJ | 1 |
| Guo, R | 1 |
| Dong, YC | 1 |
| Qin, CY | 1 |
| Lankisch, PG | 1 |
2 trials available for indomethacin and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
[Methods of acute pancreatitis prevention after endoscopic transpapillary interventions].
Topics: Administration, Rectal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Anti-Inflam | 2015 |
Pancreatic Stent or Rectal Indomethacin-Which Better Prevents Post-ERCP Pancreatitis?: A Propensity Score Matching Analysis.
Topics: Administration, Rectal; Adult; Anti-Inflammatory Agents, Non-Steroidal; China; Cholangiopancreatogra | 2016 |
1 other study available for indomethacin and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
Topics: Cholangiopancreatography, Endoscopic Retrograde; Cyclooxygenase Inhibitors; Humans; Incidence; Indom | 2008 |